Comparison of Dapagliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized,Open-Label, Active-Controlled Trial
Not Applicable
- Conditions
- type 2 diabetes mellitus, NAFLD, NASH
- Registration Number
- JPRN-UMIN000030548
- Lead Sponsor
- Saitama Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with diabetes complications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c, hepatic attenuation compared with spleen on CT scan imaging
- Secondary Outcome Measures
Name Time Method